HIV and ageing: study aims Aim: to examine the effects of ageing on medical and social outcomes of people living with HIV Example research questions: -

Slides:



Advertisements
Similar presentations
Applying the Nursing Process to Drug Therapy
Advertisements

European Guidelines for the HIV Treatment Esteban Martínez Infectious Diseases Unit Hospital Clínic University of Barcelona Barcelona SPAIN.
Medium-term prognosis of an incident cohort of people with Parkinson’s and their carers vs a community-based control group Carl Counsell.
Unmet need for family planning and low rates of dual method protection among men and women attending HIV care and treatment services in Kenya, Namibia.
EUROACTION: Changes in diet and physical activity over one year in a family based preventive cardiology programme in hospital and general practice Jennifer.
Improving health outcomes across England by providing improvement and change expertise How to Measure Patient Activation Measuring Patient Activation In.
“Effects of the Croí CLANN structured lifestyle modification programme on anthropometric and metabolic characteristics in severely obese adults” Irene.
Background  Hypertrigliceridaemia is common in patients with HIV, especially those taking protease inhibitors (PIs) or with lipodystrophy.  Although,
Journal Club Alcohol, Other Drugs, and Health: Current Evidence July–August 2013.
HIV Risk Behaviors and Alcohol Intoxication among Injection Drug Users in Puerto Rico Tomás D. Matos, MS Center for Addiction Studies Universidad Central.
Department of Health and Human Services Measuring Clinical Lab Ordering Quality: Theory and Practice Steven M. Asch MD MPH VA, RAND, UCLA April 29, 2005.
1 Lauren E. Finn, 2 Seth Sheffler-Collins, MPH, 2 Marcelo Fernandez-Viña, MPH, 2 Claire Newbern, PhD, 1 Dr. Alison Evans, ScD., 1 Drexel University School.
Copyright © 2013 by Mosby, an imprint of Elsevier Inc. Importance of Health Assessment DSN Kevin Dobi, MS, APRN.
1 Journal Club Alcohol, Other Drugs, and Health: Current Evidence September–October 2010.
Atorvastatin in Factorial with Omega-3 fatty acid Risk Reduction in Diabetes …in an academic collaboration with.
HIV Disease in Older Patients Donna M. Gallagher, ANP The International AIDS Society–USA DM Gallagher, ANP. Presented at IAS–USA/RWCA Clinical Conference,
Pregnancy Outcome Prediction Study University Department of Obstetrics and Gynaecology; PI – Professor Gordon CS Smith BACKGROUND The current pattern of.
Barbara Mukasa, Esther Kawuma, Ritah Nakigudde, Yvonne Karamagi, Micheal Ssonko, Daniel Mwehire, Sanni Yaya, Eric Druyts, Caroline MacLeod, Yvonne Karamagi,
Journal Club Alcohol, Other Drugs, and Health: Current Evidence May-June 2008.
Interpreting Adverse Signals in Diabetes Drug Development Programs Featured Article: Clifford J. Bailey, Ph.D. Diabetes Care Volume 36: 1-9 July, 2013.
Proposed study on HIV and ageing As HIV mortality rates have dropped, an increasing proportion of individuals are living with HIV to older ages As HIV.
Feedback from Pregnancy research group UK CHIC / UK HIV Drug Resistance Database Meeting, 2 July 2010 Pregnancy Group: Jane Anderson, Loveleen Bansi, Susie.
Antiretroviral Treatment Costs in Mexico WHO/UNAIDS Workshop on Strategic Information for Anti-Retroviral Therapy Programmes 30 June to 2 July, 2003 Assessment.
® Introduction Low Back Pain Remedies and Procedures: Helpful or Harmful? Lauren Lyons, Terrell Benold, MD, Sandra Burge, PhD The University of Texas Health.
Braveheart Braveheart recruits and trains volunteer mentors to run self-help groups for people who suffer angina or have had a heart attack. Aims: To.
Health Resources and Services Administration Maternal And Child Health Bureau Healthy Start What’s Happening Maribeth Badura, M.S.N. Dept. of Health and.
Uptake of antiretrovirals in a cohort of women involved in high risk sexual behaviour in Kampala, Uganda J.Bukenya, M. Kwikiriza, O. Musana, J. Ssensamba,
1FHI 360 Nigeria. 2USAID Nigeria
Multiple Choice Questions for discussion
MUNROS is funded by the European Commission FP7 programme Leads: Christine Bond and Bob Elliott University of.
Texas Medical Monitoring Project (MMP) Meeting Omni Austin Hotel at Southpark Thursday, May 31, 2007 a multi-stage probability sample of HIV infected adults.
PMTCT at Different Levels of Care: The Uganda Experience Dr. Saul Onyango National PMTCT Coordinator Ministry of Health 1 1.
Patient Empowerment Impacts Medication Adherence among HIV-Positive Patients in the Veteran’s Health Administration Tan Pham 1,2,3, Kristin Mattocks 1,2,
DRAFT BHIVA GUIDELINES Routine monitoring of HIV UK-CAB 31 July 2009 Matt Williams writing committee community rep.
Mental Health, Community and Child data Supplier Forum, February 2013 Netta Hollings – Programme Manager.
Oral Bisphosphonate and Breast Cancer: Prospective Results from the Women’s Health Initiative (WHI) Chlebowski RT et al. SABCS 2009; Abstract 21.
Family Health Days: An innovative approach to providing integrated health services for HIV and non- communicable diseases among adults and children in.
Study Designs Afshin Ostovar Bushehr University of Medical Sciences Bushehr, /4/20151.
1 Experience HealthND Medicaid Health Management Program.
Orientation on HIV care and ART Recording and Reporting System.
Health Care of at Risk Aggregate: Low Income Pregnant Women Kelley Deaton College of Nursing University of Central Florida.
NURSETRI, Nursing role in HIV care : an overview Jane Bruton Clinical Research Nurse.
The Health Roundtable Connecting Care in the Community Presenter: Nicole McDonald, Manager Ongoing and Complex Care, CCLHD Central Coast LHD - NSW Innovation.
Task Shifting in Malawi around delivery of antiretroviral therapy Anthony D Harries “The Union” Paris, France.
ABSTRACT Diabetes is a public health issue of growing magnitude. It currently ranks among the top ten leading causes of death in the United States. To.
I. Jean Davis, PhD, PA, AAHIVS Manager - Clinical Services Desert AIDS Project.
MATERIAL & METHODS SECTION PREPARATION (IN THE HEALTH RESEARCH PROPOSAL) DR. HAYFAA A. WAHBI ASSISTANT PROFESSOR, CHAIR OF EBHC & KT COLLEGE OF MEDICINE.
Integrated Care Management. Population Management Model Supported Self Care Care Management Health Promotion Population wide prevention Care coordination.
Do continuity and co-ordination of care influence quality of care and health outcomes? Stephen Campbell, David Reeves, Elizabeth Middleton, Martin Roland.
1 Impact of Implementing Designed Nursing Intervention Protocol on Clinical Outcome of Patient with Peptic Ulcer By Amal Mohamed Ahmad Assistant Professor,
Clinical Research and Outcomes Registry Workshop Creating an Informed Consent Form Daniel Ford, MD, MPH Joseph Carrese, MD.
Efficacy of a “One-Shot” Computerized, Individualized Intervention to Increase Condom Use and Decrease STDs among Clinic Patients with Main Partners Diane.
The Burden of Angina Summary and Comment by Harlan M. Krumholz, MD, SM Published in Journal Watch Cardiology March 25, 2009Journal Watch Cardiology In.
Brittle N 1, Mant J 2, McManus R 1, Lasserson D 3, Sackley C 1 Are TIAs as transient as the name suggests?
© Imperial College LondonPage 1 Professor Azeem Majeed Department of Primary Care & Social Medicine, Faculty of Medicine, Imperial College London. “Using.
Broadening the Study of Risk & Protective Factors for Depression, Drug Use, and HIV Risk among YMSM Healthy Young Men’s Study (HYM) Community, Health Outcomes,
ICPs for HIV care in NHS Tayside Morgan Evans Clinical lead.
Interventions to Improve Physical Activity and Fatigue for Older Patients Receiving Cancer Treatment Karen M. Mustian, Ph.D., M.P.H. Director and Associate.
Pharmacy Health Information Technology Collaborative Presenter: Shelly Spiro RPh, FASCP Pharmacy HIT Collaborative, Executive Director.
Private and confidential Community Pharmacy Future Four-or-more medicines support service Update on progress and next steps Approved18 th June 2012 This.
Is it possible to predict New Onset Diabetes After Transplantation (NODAT) in renal recipients using epidemiological data alone? Background NODAT is an.
Introduction Data Statistical Methods Table 1: Prevalence of Prior Hip Fracture and Incidence of New Hip Fractures and Fractures of Any Type.
Requirements to run clinical trials: Research fee calculation, patient consent Kyoung Hwa Ha.
Prescribers More likely to select medications based on patient rather than guidelines Incorporates treatment of comorbidities with relation to medication.
Women’s Interagency HIV Study (WIHS)
ART and toxicities: CNS
Management of Type II Diabetes
The What, Why and When? of Annual Studies
CONDUCTING THE TRIAL AT
Baseline Demographic Characteristics of Adults With Diagnosed Heart Failure and Eligible to Receive Lipid-Lowering Therapy Alan S. Go, et al.
Presentation transcript:

HIV and ageing: study aims Aim: to examine the effects of ageing on medical and social outcomes of people living with HIV Example research questions: - What is incidence of medical complications in older HIV- positive people; what are impacts of ARVs, co-morbidities, virological/immunological status on incidence of these? - What are outcomes of complications in older HIV-positive people; how do these compare to controls? - Do plasma concentrations of ARV drugs change with age? - How do sexual behaviours and relationship patterns differ between younger and older HIV-positive patients? - What health services are used by older HIV-positive people and do these differ from controls?

HIV and ageing: study group Alan Winston: study co-ordination; CNS manifestations Caroline Sabin: study co-ordination; cohort design; statistical support Frank Post: renal and CV disease Marta Boffito: pharmacokinetic studies, CV disease Martin Fisher: resource utilisation; sexual health and behaviour Jane Anderson: treatment of women; behavioural and social aspects of HIV infection Jonathan Elford: behavioural and social research Ian Williams: HIV management and models of care Alec Miners: Health economics Memory Sachikonye: community liaison Karen Walker-Bone: rheumatology Paddy Mallon: bone disease John Cason: sample storage Neil Poulter: Imperial Clinical Trials Unit

HIV and ageing: study design Nested cohorts within UK CHIC and demographically matched HIV-negative controls HIV-positive cases: 900 HIV-positive subjects aged >50 years HIV-positive controls: 450 HIV-positive subjects, 150 aged , and years, matched to cases for sex, ethnicity, sexual orientation, geographical location HIV-negative controls: 500 HIV-negative controls aged >50 years, matched to cases for age, sex, ethnicity, sexual orientation and geographical location Five-year study – Baseline plus three annual visits

HIV and ageing: study design HIV-positive subjects recruited from UK CHIC clinics Use of UK CHIC infrastructure and sampling frame to identify eligible HIV-positive subjects will minimize data collection costs Eligible patients selected randomly using clinic lists Patients will be contacted by clinicians to discuss participation; interested subjects will meet with study nurse who will provide written information HIV-negative controls recruited through HIV/GUM clinics, HIV/gay press, community organisations and churches

HIV and ageing: monitoring of subjects Baseline visit Demographics – age, sex, ethnicity, sexual orientation, country of birth, socioeconomic status Full clinical assessment – clinical and family history, lifestyle factors, anthropometrics, medications, adherence assessment Neurocognitive function – memory and motor function testing Quality of life and depression Pain assessment Sexual behaviour DXA scan Laboratory tests – renal, liver, lipid and bone profiles, glucose, thyroid function, FBC, sexual health screen, HCV serology, vitamin D levels Blood/urine samples stored

HIV and ageing: monitoring of subjects Annual follow-up visits Clinical examination, changes to lifestyle and socioeconomic status Significant clinical events – CV events, renal or liver failure, diabetes, malignancies, falls, fractures, joint disease, joint replacements Access to health care services – visits to GP, hospital, counsellors, psychiatrists, psychologists, medical investigations Assessment of fracture risk, neurocognitive function, quality of life and depression Pain Sexual behaviour Laboratory tests – as baseline Blood/urine samples stored at each visit (HIV-positive subjects) and at year 2 (HIV-negative controls)

HIV and ageing: work packages WP1: Data collection and management (A Winston, C Sabin) WP2: Clinical manifestations (F Post, A Winston, P Mallon, K Walker-Bone, J Anderson) WP3: Antiretroviral pharmacokinetics and drug interactions (M Boffito) WP4: Sexual health (J Elford, J Anderson, M Fisher) WP5: Socioeconomic circumstances (J Anderson, J Elford) WP6: Resource utilization and service delivery (I Williams, M Fisher, A Miners) WP7: Community involvement (M Sachikonye)

HIV and ageing: Current status Stage 1 application for programme grant to NIHR was successful Full stage 2 application due mid-October If successful, notified in March 2011 Awards commence – October 2011